
Volume 13, Number 1 (Jan/Feb 2022)
SOHO Highlights and Commentary: The Advanced Practitioner Perspective
Selected Presentations From the 9th Annual Meeting of the Society of Hematologic Oncology
This supplement to JADPRO provides an overview of presentations from the 2021 Annual Meeting of the Society of Hematologic Oncology (September 8–11), along with expert commentary that aims to contexualize the information presented at SOHO for the advanced practitioner.
Guest Editor
Alexis C. Geppner, MLS, CTTS, PA-C
The University of Texas MD Anderson Cancer Center
Lisa Nodzon, PhD, ARNP, AOCNP®
H. Lee Moffitt Cancer Center and Research Institute
Kelly Valla, PharmD, BCOP
Winship Cancer Institute of Emory University
IDH-Mutated AML: Beyond Enasidenib and Ivosidenib Monotherapy: Highlights From SOHO 2021
January 26, 2022
BCMA-Directed CAR T Cells in Relapsed Refractory Multiple Myeloma: Highlights From SOHO 2021
January 26, 2022
The Next Wave of Novel Agents in Aggressive B-Cell Lymphoma: Highlights From SOHO 2021
January 26, 2022
Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma: Highlights From SOHO 2021
January 26, 2022
Current Issue


Pain as the Fifth Vital Sign Challenges in Managing Cancer Related Pain
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
September 17, 2025
Women With Gynecologic Cancers: Screening for Substance Use Disorders Is Key
Lindsay Shor, DNP, WHNP-BC, Alison Edie, DNP, APRN, FNP-BC, Kathryn Trotter, DNP, CNM, FNP-BC, FAANP, FAAN Et al.
September 17, 2025
Tumor Treating Fields An Innovative Therapy for Glioblastoma and Other Solid Tumors
Jennifer N. Serventi, PA-C, Herbert B. Newton, MD
September 17, 2025